Clinical significance of P16-positive status and high index of proliferative activity in patients with oropharyngeal squamous cell carcinoma
https://doi.org/10.21294/1814-4861-2020-19-2-41-48
Abstract
Introduction. In accordance with uICC and AJCC 8th edition TNM classifications, there is a strong evidence for division of oropharyngeal squamous cell carcinoma (OPSCC) into 2 molecular subtypes by HPV-status with distinct prognosis depending on biological differences. Such a division leads to differences in staging OPSCC and in future it will lead to implementation of preventive measures and new therapeutic strategies against HPV-positive cancer.
Aim of the study: to assess the clinical and prognostic significance of the combination of P16, a surrogate marker for HPV-positivity, and high proliferative activity in patients with oropharyngeal carcinoma.
Material and Methods. Immunohistochemical (ICH) analysis with monoclonal antibodies specific for P16 and Ki67 proteins was used to detect expression patterns in the formalin-fixed, paraffin-embedded tumor samples obtained from 104 patients with squamous cell carcinoma of the tongue and oropharynx, treated at Oncological Dispencery № 1 in Krasnodar from 2011 to 2016. HPV-positive status was determined if more than 70 % of tumor cells had moderate or strong nuclear and cytoplasmic P16-staining. High index of proliferative activity (PA) was detected if more than 50 % tumor cells expressed Ki67 nuclear antigen.
Results. P16-positivie status was associated with tonsillar cancer (р=0.002), female gender (р=0.015), age <60 years (р<0.001), non - keratinizing morphology (р=0.022), and high index of PA (p=0.01).The combination of P16>70 % with high PA demonstrated correlation with tonsillar cancer (р<0.001), female gander (р=0.015), age under 60 years (р<0.001) and non - keratinizing morphology (р=0.012). HPV-positive patients and patients with a combination of P16>70 % and high index of PA at N1-2 had an overall survival benefit (p=0.021).
Conclusion. The correlation between IHC-complex for P16>70 %/Ki67>50 % and clinicopathologicl parameters and overall survival confirms the biological features of HPV-associated cancer. The evaluation of this IHC-complex can increase the diagnostic accuracy of IHC-analysis of HPV-status and predict the prognosis of patients with OPSCC.
About the Authors
A. I. StukanRussian Federation
Anastasia I Stukan - oncologist, CDO. Researcher ID (WOS): E-5524-2019. ORCID: 0000-0002-0698-7710.
146, Dimitrova Street, 350040-Krasnodar; 4, Mitrofana sedina street, 350063-Krasnodar
V. A. Porkhanov
Russian Federation
Vladimir A. Porkhanov, DSc, Professor, Academician RAS, Head of Scientific Investigational Institute State Clinical Hospital № 1 named by professor S.V Ochapovsky; Head of Department of Oncology with Course of Thoracic Surgery of KSMU. Researcher ID (WOS): O-9470-2017.
167, May 1 street, 350086-Krasnodar; 4, Mitrofana sedina street, 350063-Krasnodar
V. N. Bodnya
Russian Federation
Vadim N. Bodnya - DSc, Department of Oncology with Course of Thoracic Surgery of KSMU. Researcher ID (WOS): F-2670-2019. ORCID: 0000-0003-3169-9558.
4, Mitrofana sedina street, 350063-Krasnodar
References
1. The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015 Jan 29; 517(7536): 576-82. doi: 10.1038/nature14129.
2. GallowayD.A., LaiminsL.A. Human papillomaviruses: shared and distinct pathways for pathogenesis. Curr Opin Virol. 2015 Oct; 14: 87-92. doi: 10.1016/j.coviro.2015.09.001.
3. Kaprin A.D., Starinckiy V.V., Petrova G.V The state of cancer care in Russia in 2018. Moscow; 2019. 250 p. (in Russian).
4. Jiron J., Sethi S., Ali-Fehmi R., Franceschi S., Struijk L., van Doorn L.J., Quint W., Kato I. Racial disparities in Human Papillomavirus(HPV) associated head and neck cancer. Am J Otolaryngol. 2014 Mar-Apr; 35(2): 147-53. doi: 10.1016/j.amjoto.2013.09.004.
5. Cheremisina O.V, Choinzonov E.L., Pankova O.V., MukhamedovM.R., UrazovaL.N., Dvorianinova O.Yu. Papillomatosis as a criteria for the formation of the group at risk of laryngeal cancer. Bulletin Otorinolaringology. 2015; 80(1): 39-43. (in Russian).
6. Grоnhоj L.C., Gylden^ve M., Jensen D.H., Therkildsen M.H., Kiss K., Norrild B., Konge L., von Buchwald C. Correlation between human papillomavirus and P16 overexpression in oropharyngeal tumours: a systematic review. Br J Cancer. 2014 Mar 18; 110(6): 1587-94. doi: 10.1038/bjc.2014.42.
7. Galloway D.A., Laimins L.A. Human papillomaviruses: shared and distinct pathways for pathogenesis. Curr Opin Virol. 2015 Oct; 14: 87-92. doi: 10.1016/j.coviro.2015.09.001.
8. Wang Z., Xia R.H., Ye D.X., Li J. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population. PLoS One. 2016 Oct 17; 11(10): e0164491. doi: 10.1371/journal.pone.0164491.
9. JohnsonM.E., CantalupoP.G., Pipas J.M. Identification of head and neck cancer subtypes based on human papillomavirus presence and E2F-regulated gene expression. mSphere. 2018 Jan 10; 3(1). pii: e00580-17. doi: 10.1128/mSphere.00580-17.
10. Huang S.H., O'Sullivan B. Overview of the 8th Edition TNM Classification for Head and Neck Cancer. Curr Treat Options Oncol. 2017 Jul; 18(7): 40. doi: 10.1007/s11864-017-0484-y.
11. PriggeE.S., ArbynM., vonKnebelDoeberitz M., ReuschenbachM. Diagnostic accuracy of P16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis. Int J Cancer. 2017 Mar 1; 140(5): 1186-98. doi: 10.1002/ijc.30516.
12. Lewis J.S.Jr. P16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol. 2012 Jul; 6 Suppl 1: S75-82. doi: 10.1007/s12105-012-0369-0.
13. Lewis J.S.Jr., Beadle B., Bishop J.A., ChernockR.D., Colasacco C., Lacchetti C., Moncur J.T., Rocco J.W., Schwartz M.R., Seethala R.R., Thomas N.E., Westra W.H., Faquin W.C. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists. Arch Pathol Lab Med. 2018 May; 142(5): 559-97. doi: 10.5858/arpa.2017-0286-CP
14. Mielcarek-Kuchta D., Olofsson J., Golusinski W. p53, Ki67 and cyclin D1 as prognostic factors of lymph node metastases in laryngeal carcinoma. Eur Arch Otorhinolaryngol. 2003; 260(10): 549-54. doi: 10.1007/s00405-003-0651-6.
Review
For citations:
Stukan A.I., Porkhanov V.A., Bodnya V.N. Clinical significance of P16-positive status and high index of proliferative activity in patients with oropharyngeal squamous cell carcinoma. Siberian journal of oncology. 2020;19(2):41-48. https://doi.org/10.21294/1814-4861-2020-19-2-41-48